Rectovaginal Fistula Market Introduction
Rectovaginal fistula can be described as abnormal epithelial line connected between the rectum and vagina. Fistulas can be the outcome of acquired etiologies or congenital malformations. Rectovaginal fistulas can also be caused due to childbirth. Obstetric injury with a fourth or a third degree perineal tear or prolonged labor with necrosis of the part or episiotomy could result in rectovaginal fistula. Infection, breakdown of the repair, or improper repair can lead to development of fistula. Infections caused within the rectovaginal septum can lead to the condition. Bartholin gland infections and Cryptoglandular anorectal abscess drains cause low rectovaginal fistula.
Hysterectomy is performed due to infection caused due to high fistula. Lymph granuloma venereum and tuberculosis also can result in rectovaginal fistula. Primary classification of the condition is done with the help of etiology, size, and location. It categorizes the criteria for rectovaginal fistulas as complex or simple. Classification of fistula is performed to plan proper treatment and appropriate therapy. Fistulas greater than 2.5 cm in diameter are termed as large and those less than 2.5 cm are considered small. It can be difficult to a patient and surgeon due to the embarrassing and irritating symptoms and also the high failure rates faced after repair.
Identify the key factors that will drive your company’s growth. Request a brochure of this report here
Rectovaginal Fistula Market- Competitive Landscape
The major factors promoting the growth of rectovaginal fistula market include growing R&D budgets by both government as well as commercial pharmaceutical and biotechnological companies. For instance, in the year 2013, the fistula care project that was implemented by EngenderHealth, was funded by the US Agency for International Development, and supported by the following hospitals namely, Jean Paul II Hospital (Conakry), Labé Regional Hospital (Labé), and Kissidougou Prefectural Hospital (Kissidougou).
Takeda Pharmaceutical Company
Takeda Pharmaceutical Company Limited, was established in the year 1781 and is headquartered in Tokyo, Japan. The company is engaged in the research and development, s well as manufacturing and marketing of pharmaceutical drugs, OTC medicines, consumer products, and other healthcare products.
Founded in 1963, Cook medical is engaged in the designing, manufacturing, and distribution of minimally invasive medical devices used for diagnostic as well as therapeutic procedures. The products offered by the organization includes introducer sheaths, airway management devices, catheters, wire guides, vena cava filters, stents, embolization coils, aortic endovascular grafts, central venous catheter devices, and drainage products.
The company was founded in 1849. Pfizer Inc. is engaged in the discovery, development, manufacturing, and selling of healthcare products across the world. The products offered by the company include medicines and vaccines in varied therapeutic sectors, including inflammation and immunology, vaccines, oncology, internal medicine, and rare diseases
Expanding operations in future? To get the perfect launch ask for a custom report here
Rectovaginal Fistula Market Dynamics
Rise in Prevalence of Crohn’s Disease Resulting in Occurrence of Rectovaginal Fistula
Crohn's disease can be defined as an inflammatory bowel disease wherein there is an inflammation of the digestive tract lining. Large number of women suffering from Crohn’s disease never develop a rectovaginal fistula. However, suffering from Crohn’s disease increases the risk of this condition. Thus, owing to the increasing problem of Crohn’s disease, the prevalence of rectovaginal fistula will increase in forecast period.
An Increase in Injuries during Childbirth Leading To High Rectovaginal Fistula Market Growth
The most common factor causing rectovaginal fistulas include delivery-related injuries. This includes perineum tears that extends till the bowel, or an episiotomy infection which is a surgical incision conducted to enlarge the perineum during the course of vaginal delivery. These may occur post a long, difficult, or otherwise obstructed labor. These kind of fistulas may also comprise injury to anal sphincter, the muscle rings at the end of the rectum that aids a person to hold. Thus, due to an increase in the rate of childbirth injuries, the incidence rate rectovaginal fistula suppressors is estimated to increase during the forecast period.
Surgery In Areas Such As Vagina, Perineum, Rectum Or Anus Or Radiation Treatment In Pelvic Area
The presence of cancerous tumor in regions such as uterus, rectum, vagina, anal canal or cervix, can lead to development of rectovaginal fistula. Also, the radiation therapy undertaken for cancers in these body parts also increases the risk of development of rectovaginal fistulas. The prior occurrence of surgery in lower pelvic region, such as hysterectomy can also result in development of rectovaginal fistula. Thus, due to an increase in prevalence of pelvic cancer and surgery in lower pelvic region, the rectovaginal fistula market is bound to flourish.
Rectovaginal fistula Market Segmentation
Based on the diagnosis type, the rectovaginal fistula market is segmented into
- physical exam
- Contrast Tests
- Blue Dye Tests
- computerized tomography (CT) scan
- magnetic resonance imaging (MRI)
- Anorectal Ultrasound
- Anorectal manometry
Based on the treatment type, the rectovaginal fistula market is segmented into
Based on the end-user , the rectovaginal fistula market is segmented into
- Hospitals & Clinics
- Diagnostic Centers
- Research Organizations & Academic Institutions
The report on rectovaginal fistula market is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The rectovaginal fistula market report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The rectovaginal fistula market report also maps the qualitative impact of various market factors on market segments and geographies.
Regional analysis for rectovaginal fistula market includes:
- North America
- Asia Pacific
- Middle East & Africa (MEA)
- Latin America
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.